🔴 Hims Hers Health is trading 4.1% down today after earnings release showed margin compression

Hims Hers Health is trading 4.1% down now at $29.27 after investors continued selling following the August 10 earnings release.

• Revenue beat expectations at $753.2 million, but the company reported a $0.37 per-share loss; gross margin fell to 64% and adjusted EBITDA margin declined to 8%.
• The branded GLP-1 transition created restructuring costs and pressured profitability.
• Citi subsequently reduced its price target to $33 from $35.